A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer

Clinical trial NCT03811418 · WITHDRAWN

Trial details

NCT number: NCT03811418
Sponsor: iOMEDICO AG
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced Breast Cancer HER2-positive Breast Cancer

Start date: 2019-01-01
Primary completion: 2019-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.